Related Experiment Video
Updated: Jul 30, 2025
11:44
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
7.7K
In Silico Analysis of MicroRNA Expression Data in Liver Cancer
Nourhan Abu-Shahba1,2, Elsayed Hegazy3, Faiz M Khan4
1Department of Medical Molecular Genetics, Human Genetics and Genome Research Institute, National Research Centre, Cairo, Egypt.
Cancer Informatics
|May 18, 2023
Summary
This study identified 34 differentially expressed microRNAs (miRNAs) linked to hepatocellular carcinoma (HCC). Specific miRNAs and their targets show potential as diagnostic and therapeutic biomarkers for HCC, with POU2F1 and PPARA impacting patient survival.
Area of Science:
- Oncology
- Genetics
- Bioinformatics
Background:
- Abnormal microRNA (miRNA) expression is implicated in hepatocellular carcinoma (HCC) development and progression.
- Identifying specific miRNAs can aid in understanding HCC pathogenesis and developing targeted therapies.
Purpose of the Study:
- To computationally identify prognostic, diagnostic, and therapeutic miRNAs for HCC.
- To analyze miRNA expression patterns and their associated target genes in HCC tissues.
Main Methods:
- Meta-analysis of miRNA expression datasets using YM500v2 to compare normal and cancerous liver tissues.
- Target gene analysis with mirWalk and miRror Suite, followed by functional enrichment analysis using DAVID.
- Construction of a regulatory network and identification of hub/gatekeeper nodes, with survival analysis of patient data.
Main Results:
- 34 significantly differentially regulated miRNAs (29 up-regulated, 5 down-regulated) were identified (P ≤ 0.05).
- Enrichment analysis revealed involvement in key cancer pathways like focal adhesion and PI3K-Akt signaling.
- POU2F1 and PPARA were identified as significant prognostic factors associated with HCC patient survival.
Conclusions:
- This study highlights potential biomarker miRNAs and their target genes for HCC diagnosis and therapy.
- Identified hub genes and gatekeepers offer potential therapeutic targets for hepatocellular carcinoma.
- Specific miRNAs and transcription factors like POU2F1 and PPARA are crucial for HCC patient prognosis.
Related Concept Videos
01:22MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
02:39lncRNA - Long Non-coding RNAs
8.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K